Nasdaq ubx.
Shares of Unity Biotechnology ( UBX -1.60%) fell over 20% today, before sharply recovering. This came after the company reported data from a phase 1 clinical trial for its lead drug candidate ...
UBX; ISIN: US91381U2006; Market cap: $26.72 million; Shares in issue: 14.62 million; Sector: Biotechnology; Exchange: NASDAQ; Country: United States; Currency: ...SAN FRANCISCO, Feb. 25, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or ...Nov 18, 2023 · HC Wainwright restated their buy rating on shares of Unity Biotechnology (NASDAQ:UBX – Free Report) in a report published on Tuesday morning, Benzinga reports. HC Wainwright currently has a $10.00 price target on the stock. HC Wainwright also issued estimates for Unity Biotechnology’s Q4 2023 earnings at ($1.15) EPS, FY2024 earnings at ($3.83) EPS, FY2025 […] SOUTH SAN FRANCISCO, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...Unity Biotechnology, Inc. (NASDAQ: UBX) is a South San Francisco based mid-clinical-stage healthcare concern developing treatments that “ slow, halt, or reverse diseases of aging,” with a ...
(NASDAQ: UBX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.13%. What is UBX's Price Target? According to 4 Wall Street analyst s that have issued a 1 year UBX price target, the average UBX price target is $7.00 , with the highest UBX stock price forecast at $10.00 and the lowest UBX stock price ...Unity Biotechnology, Inc. Common Stock (UBX) Stock Price, Quote, News & History | Nasdaq. when trading, helping you to optimize your price and have a successful order execution. Nasdaq Data...
SOUTH SAN FRANCISCO, Calif., Aug. 16, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of ...
Unity Biotechnology, Inc. ( NASDAQ:UBX ) shareholders should be happy to see the share price up 23% in the last week...SOUTH SAN FRANCISCO, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of ...SOUTH SAN FRANCISCO, Calif., Nov. 04, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of ...SOUTH SAN FRANCISCO, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of ...Follow. SOUTH SAN FRANCISCO, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or ...
Oct 17, 2023 · Unity Biotechnology (NASDAQ: UBX) primarily focuses on developing therapeutics targeting age-related ophthalmologic and neurologic diseases. Its main candidate, UBX1325, is being studied for ...
UNITY Biotechnology stock quote and UBX charts. Latest stock price today and the US's most active stock market forums.
Unity Biotech sheds 48% after mid-stage setback for wet AMD candidate. Unity Biotechnology ( NASDAQ: UBX) lost ~48% pre-market Monday after announcing that its lead candidate UBX1325 failed to ...– Topline 12-week results for Phase 2 study of UBX0101 in osteoarthritis expected in 3Q 2020 – – First-in-human study for UBX1325 in age-related eye disease expected to commence in 2H 2020 –74.86. +0.25%. 17.03M. View today's Unity Biotechnology Inc stock price and latest UBX news and analysis. Create real-time notifications to follow any changes in the live stock price.SOUTH SAN FRANCISCO, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...SOUTH SAN FRANCISCO, Calif., Nov. 04, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of ...Aug 5, 2022 · Unity Biotechnology, Inc. (NASDAQ:UBX) shareholders should be happy to see the share price up 23% in the last month. But only the myopic could ignore the astounding decline over three years. SOUTH SAN FRANCISCO, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...
Nov 18, 2023 · Unity Biotechnology Inc (NASDAQ:UBX) trade information. Upright in the green during last session for gaining 17.68%, in the last five days UBX remained trading in the green while hitting it’s week-highest on Friday, 11/17/23 when the stock touched $2.13 price level, adding 1.39% to its value on the day. SOUTH SAN FRANCISCO, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse ...UBX. Unity Biotechnology, Inc. 1.8300 +0.1100 ... The S&P 500 has surged by 7% this month, while the tech-focused Nasdaq has shown even stronger growth, with gains of approximately 10%. Watching ...Wedbush analyst Andreas Argyrides upgraded the shares of Unity Biotechnology Inc (NASDAQ:UBX) from Neutral to Outperform and raised the price target from $2 to $4.Unity Biotechnology, Inc. UBX NASDAQ.Unity Biotechnology Inc (NASDAQ:UBX)’s traded shares stood at 0.1 million during the last session, with the company’s beta value hitting 0.54. At the close of trading, the stock’s price was $2.02, to imply a decrease of -1.94% or -$0.04 in intraday trading. The UBX share’s 52-week high ...Nov 23, 2023 · Unity Biotechnology Inc (NASDAQ:UBX)’s traded shares stood at 0.1 million during the last session, with the company’s beta value hitting 0.54. At the close of trading, the stock’s price was $2.02, to imply a decrease of -1.94% or -$0.04 in intraday trading. The UBX share’s 52-week high ...
Last November, Wedbush analyst Andreas Argyrides raised his price target on Unity Biotechnology, Inc. (NASDAQ:UBX) to $36 from $4 and maintained an Outperform rating on the shares.
NASDAQ:UBX - Unity Biotechnology Stock Price, News & Analysis Unity Biotechnology Stock Price, News & Analysis (NASDAQ:UBX) $1.95 +0.03 (+1.56%) (As of 03:45 PM …SOUTH SAN FRANCISCO, Calif., Aug. 12, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...Unity Biotechnology upgraded to Outperform from Neutral at Wedbush November 16, 2023TipRanks. Unity Biotechnology’s Promising Senolytic Therapy UBX1325 and Financial Stability Bolsters Buy ...Aug 8, 2023 · SOUTH SAN FRANCISCO, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of ... SOUTH SAN FRANCISCO, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse ...Nov 28, 2023 · According to the issued ratings of 4 analysts in the last year, the consensus rating for Unity Biotechnology stock is Buy based on the current 4 buy ratings for UBX. The average twelve-month price prediction for Unity Biotechnology is $6.50 with a high price target of $10.00 and a low price target of $4.00. Learn more on UBX's analyst rating ... Their UBX share price targets range from $4.00 to $10.00. On average, they predict the company's stock price to reach $6.50 in the next year. This suggests a possible upside of 238.5% from the stock's current price. View analysts price targets for UBX or view top-rated stocks among Wall Street analysts. Real time Unity Biotechnology (UBX) stock price quote, stock graph, news & analysis.In the previous quarter, Unity Biotechnology (NASDAQ:UBX) reported ($0.67) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.87) by $0.20. Learn more on analysts' earnings estimate vs. UBX's actual earnings.
Oct 5, 2022 · At $8, the average UBX price target implies upside potential of 1,829%. At writing, shares are trading at $0.41 for a market cap of approximately $56.8 million and has a 52-week range of $0.38 ...
SOUTH SAN FRANCISCO, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...
Unity Biotechnology upgraded to Outperform from Neutral at Wedbush November 16, 2023TipRanks. Unity Biotechnology’s Promising Senolytic Therapy UBX1325 and Financial Stability Bolsters Buy ...52-week range: $0.42 – $3.64 Unity Biotechnology (NASDAQ:UBX) focuses primarily on the development of therapeutics that target age-related ophthalmologic and neurologic diseases.. Its central ...UBX; ISIN: US91381U2006; Market cap: $26.72 million; Shares in issue: 14.62 million; Sector: Biotechnology; Exchange: NASDAQ; Country: United States; Currency: ...Nov 24, 2023 · UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds. SOUTH SAN FRANCISCO, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY” or the “Company”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or rev... 15 days ago - GlobeNewsWire. Discover historical prices for UBX stock on Yahoo Finance. View daily, weekly or monthly format back to when Unity Biotechnology, Inc. stock was issued.SOUTH SAN FRANCISCO, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...Unity Biotechnology, Inc. (NASDAQ: UBX) is a South San Francisco based mid-clinical-stage healthcare concern developing treatments that “ slow, halt, or reverse diseases of aging,” with a ...Markets Home UBX • NASDAQ Unity Biotechnology Inc Follow Share $1.92 After Hours: $1.91 (0.52%) -0.0100 Closed: Dec 1, 7:36:27 PM GMT-5 · USD · NASDAQ · Disclaimer …(“UNITY” or the “Company”) (NASDAQ:UBX) today announced the closing of the Company's initial public offering of 5,000,000 shares of common stock at a public ...Nov 20, 2023 · The public float for UBX is 13.19M, and at present, short sellers hold a 4.92% of that float. On November 20, 2023, the average trading volume of UBX was 52.55K shares. UBX) stock’s latest price update. Unity Biotechnology Inc (NASDAQ: UBX) has experienced a rise in its stock price by 17.68 compared to its previous closing price of 1.81. UBX Latest Real Time Trades · Trending Stocks · Your symbols have been updated · Edit Watchlist · Opt in to Smart Portfolio · Privacy Preference Center. When ...SOUTH SAN FRANCISCO, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases ...
Oliver Dolan MBA, CPA. Biotech/Healthcare Finance Executive. UNITY Biotechnology Inc. (Nasdaq : UBX) MIT Sloan School of Management ...SOUTH SAN FRANCISCO, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...SOUTH SAN FRANCISCO, Calif., Jan. 18, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...Unity Biotechnology, Inc. (NASDAQ:UBX) was in 4 hedge funds’ portfolios at the end of September. UBX shareholders have witnessed a decrease in hedge fund interest recently. There were 5 hedge ...Instagram:https://instagram. best offshore brokerage accountcheap stocks to buy under dollar5 todayjewl stockgogl dividends Home UBX • NASDAQ. Unity Biotechnology Inc. Follow. Share. $1.92. After Hours: $1.91. (0.52%) -0.0100. Closed: Dec 1, 7:36:27 PM GMT-5 · USD · NASDAQ · Disclaimer.Stock analysis for UNITY Biotechnology Inc (UBX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. tmfc etfex dividend date calender Mar 15, 2022 · SOUTH SAN FRANCISCO, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases ... SOUTH SAN FRANCISCO, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ... what is the best penny stock trading platform SOUTH SAN FRANCISCO, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases ...This has heavy trading pulling shares of UBX stock lower today. Unity Biotechnology (NASDAQ: UBX) stock is taking a beating on Monday after revealing results from its Phase 2 clinical trial of ...